CA Patent

CA2346698A1 — Novel heterocyclyl-methyl-substituted pyrazoles

Assigned to Bayer AG · Expires 2000-04-20 · 26y expired

What this patent protects

The invention relates to novel heterocyclyl-methyl-substituted pyrazole derivatives, to methods for producing them and to their use as medicaments, especially as medicaments for treating cardiovascular diseases.

USPTO Abstract

The invention relates to novel heterocyclyl-methyl-substituted pyrazole derivatives, to methods for producing them and to their use as medicaments, especially as medicaments for treating cardiovascular diseases.

Drugs covered by this patent

Patent Metadata

Patent number
CA2346698A1
Jurisdiction
CA
Classification
—
Expires
2000-04-20
Drug substance claim
No
Drug product claim
No
Assignee
Bayer AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.